Selective anticancer effects of a synthetic flavagline on human Oct4-expressing cancer stem-like cells via a p38 MAPK-dependent caspase-3-dependent pathway

EMHEMMED, F., ALI AZOUAOU, S., THUAUD, F., SCHINI-KERTH, Valérie, DESAUBRY, L., MULLER, C. D. et FUHRMANN, Guy, 2014. Selective anticancer effects of a synthetic flavagline on human Oct4-expressing cancer stem-like cells via a p38 MAPK-dependent caspase-3-dependent pathway. Biochemical pharmacology [en ligne]. 2014. Vol. 89, n° 2pp. 185-196. [Consultésans date]. DOI 10.1016/j.bcp.2014.02.020. Consulté de : http://www.ncbi.nlm.nih.gov/pubmed/24607276